Embryo Ventures invests in early-stage companies at the intersection of human health and experience, focusing on transformative technologies that restore, sustain, and expand human potential. They back founders building next-generation clinical and consumer technologies, as well as innovations redefining essential systems of daily life.
About Embryo Ventures
Embryo Ventures is a UK-based venture capital firm with website, LinkedIn, and Crunchbase footprint, with positioning that suggests a focus on very early-stage technology companies, possibly with a generalist or thematic thesis. The name implies pre-seed or formation-stage investing, and the UK base suggests British and European geographic focus. The source data does not disclose specific sector, healthcare exposure, or check size detail. For healthcare AI founders, Embryo Ventures is most plausibly relevant if you are a UK or European-based founder at the very earliest stage, ideally pre-seed, building software-style healthcare AI with credible founder-market fit and a capital-efficient development plan. Plausible check sizing at this profile is GBP 50K to GBP 500K at pre-seed, with the firm potentially leading very small rounds and bringing meaningful UK ecosystem connections. Founders building biotech, regulated devices, or capital-intensive care delivery should look to specialist healthcare investors instead, and U.S. or non-European founders are unlikely to fit. The firm’s value-add is harder to predict without disclosed thesis or recent portfolio data, but pre-seed UK funds typically provide founder coaching, ecosystem connections, and bridge-to-seed capital. Entry path is LinkedIn outreach to the partners, the website inquiry form, or warm referral from a UK ecosystem operator. Founders should reverse-diligence by asking for recent investments, fund size, and any healthcare exposure before significant pitch preparation. Be honest: with this little public signal, founder time should be invested only after confirming geographic and stage fit through a brief exploratory exchange, and disclosed-thesis UK healthcare investors should be prioritized first.
Founder reviews
Other portfolio companies
Companies in Embryo Ventures's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from Embryo Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).